Gilead Sciences (GILD) Non-Current Deffered Revenue (2009 - 2013)
Gilead Sciences (GILD) posted Non-Current Deffered Revenue of $21.98 million for Q4 2013, up 7.0% from $20.53 million a year earlier but down 13.5% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Non-Current Deffered Revenue (2009 - 2013) Analysis & Trends
Since Q2 2009, Gilead Sciences has reported Non-Current Deffered Revenue for 18 quarters.
- Annual Non-Current Deffered Revenue shows a four-year compound annual growth rate of -15.5% (FY2009 to FY2013).
- In prior years, Gilead Sciences' Non-Current Deffered Revenue was $20.53 million in FY2012 (-35.6%), $31.87 million in FY2011 (-3.0%), $32.84 million in FY2010 (-23.7%) and $43.03 million in FY2009.
- Quarterly Non-Current Deffered Revenue has run from a low of $20.53 million in Q4 2012 to a high of $53.42 million in Q2 2009 over five years.
- On a year-over-year basis, Non-Current Deffered Revenue has increased in each of the last four quarters, with an average decline of 3.8% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q3 2013, with growth of 21.9%; the weakest was Q3 2012, with a decline of 40.0%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $25.4 million (Q3 2013), $28.77 million (Q2 2013) and $32.2 million (Q1 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | 21.98 Mn |
| Sep 30, 2013 | 25.40 Mn |
| Jun 30, 2013 | 28.77 Mn |
| Mar 31, 2013 | 32.20 Mn |
| Dec 31, 2012 | 20.53 Mn |
| Sep 30, 2012 | 20.84 Mn |
| Jun 30, 2012 | 23.66 Mn |
| Mar 31, 2012 | 26.51 Mn |
| Dec 31, 2011 | 31.87 Mn |
| Sep 30, 2011 | 34.70 Mn |
| Jun 30, 2011 | 27.71 Mn |
| Mar 31, 2011 | 30.28 Mn |
| Dec 31, 2010 | 32.84 Mn |
| Sep 30, 2010 | 39.45 Mn |
| Mar 31, 2010 | 41.49 Mn |
| Dec 31, 2009 | 43.03 Mn |
| Sep 30, 2009 | 44.57 Mn |
| Jun 30, 2009 | 53.42 Mn |
API Access
Gilead Sciences Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();